Compare Piramal Healthcare with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ALEMBIC PHARMA - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ALEMBIC PHARMA PIRAMAL ENTERPRISES/
ALEMBIC PHARMA
 
P/E (TTM) x 17.2 16.0 107.7% View Chart
P/BV x 1.1 4.0 28.8% View Chart
Dividend Yield % 1.6 1.0 161.6%  

Financials

 PIRAMAL ENTERPRISES   ALEMBIC PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ALEMBIC PHARMA
Mar-19
PIRAMAL ENTERPRISES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3,303664 497.4%   
Low Rs1,797412 435.7%   
Sales per share (Unadj.) Rs716.5208.7 343.3%  
Earnings per share (Unadj.) Rs79.731.0 257.1%  
Cash flow per share (Unadj.) Rs107.937.1 290.8%  
Dividends per share (Unadj.) Rs28.005.50 509.1%  
Dividend yield (eoy) %1.11.0 107.5%  
Book value per share (Unadj.) Rs1,477.5144.2 1,024.5%  
Shares outstanding (eoy) m184.45188.52 97.8%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.62.6 138.0%   
Avg P/E ratio x32.017.4 184.2%  
P/CF ratio (eoy) x23.614.5 162.9%  
Price / Book Value ratio x1.73.7 46.2%  
Dividend payout %35.117.7 198.0%   
Avg Mkt Cap Rs m470,292101,461 463.5%   
No. of employees `0007.8NA-   
Total wages/salary Rs m22,5047,467 301.4%   
Avg. sales/employee Rs Th16,899.4NM-  
Avg. wages/employee Rs Th2,877.7NM-  
Avg. net profit/employee Rs Th1,879.9NM-  
INCOME DATA
Net Sales Rs m132,15339,347 335.9%  
Other income Rs m3,12894 3,334.8%   
Total revenues Rs m135,28139,441 343.0%   
Gross profit Rs m66,2908,736 758.8%  
Depreciation Rs m5,2021,152 451.4%   
Interest Rs m44,097184 23,953.0%   
Profit before tax Rs m20,1197,493 268.5%   
Minority Interest Rs m3,19411 29,572.2%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6111,568 549.4%   
Profit after tax Rs m14,7015,844 251.6%  
Gross profit margin %50.222.2 225.9%  
Effective tax rate %42.820.9 204.6%   
Net profit margin %11.114.9 74.9%  
BALANCE SHEET DATA
Current assets Rs m122,74219,577 627.0%   
Current liabilities Rs m310,81014,896 2,086.5%   
Net working cap to sales %-142.311.9 -1,196.2%  
Current ratio x0.41.3 30.0%  
Inventory Days Days2390 25.7%  
Debtors Days Days3945 85.6%  
Net fixed assets Rs m116,90427,097 431.4%   
Share capital Rs m369377 97.9%   
"Free" reserves Rs m272,16126,811 1,015.1%   
Net worth Rs m272,53027,188 1,002.4%   
Long term debt Rs m270,1964,993 5,411.5%   
Total assets Rs m856,26147,778 1,792.2%  
Interest coverage x1.541.7 3.5%   
Debt to equity ratio x1.00.2 539.9%  
Sales to assets ratio x0.20.8 18.7%   
Return on assets %6.912.6 54.4%  
Return on equity %5.421.5 25.1%  
Return on capital %12.423.6 52.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,20019,453 78.1%   
Fx outflow Rs m4,8896,065 80.6%   
Net fx Rs m10,31213,388 77.0%   
CASH FLOW
From Operations Rs m-115,9758,120 -1,428.3%  
From Investments Rs m-8,265-7,556 109.4%  
From Financial Activity Rs m107,525590 18,212.2%  
Net Cashflow Rs m-16,6501,153 -1,443.7%  

Share Holding

Indian Promoters % 52.9 74.1 71.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 2.9 137.9%  
FIIs % 26.6 9.1 292.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 13.9 118.7%  
Shareholders   93,274 49,328 189.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Open Marginally Higher; Healthcare Stocks Witness Buying(09:30 am)

Asian share markets are trading on a negative note today as Japanese and Hong Kong shares show losses. The Nikkei 225 is down 0.79% while the Hang Seng is down 1.73%.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Nov 13, 2019 09:49 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS